Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation

S. Danese, S. Semeraro, M. Marini, I. Roberto, A. Armuzzi, A. Papa, A. Gasbarrini

Research output: Contribution to journalArticle

Abstract

Mucosal endothelium has become one of the major areas of investigation in gut inflammation. It is now well recognised that it plays an active role in the pathogenesis of both forms of inflammatory bowel disease, Crohn's disease and ulcerative colitis, since endothelial cells regulate mucosal immune homeostasis, acting as "gatekeepers", controlling leukocyte accumulation in the interstitial compartment. This process is mediated by leukocyte-endothelial adhesion molecules. This paper reviews the major molecules that mediate leukocyte-endothelial interactions, and summarises the results of the most recent clinical trials targeting adhesion molecules in inflammatory bowel disease.

Original languageEnglish
Pages (from-to)811-818
Number of pages8
JournalDigestive and Liver Disease
Volume37
Issue number11
DOIs
Publication statusPublished - Nov 2005

Keywords

  • Adhesion molecules
  • Endothelium
  • Leukocyte

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation'. Together they form a unique fingerprint.

Cite this